Table 2. Description of patients included in the cytokine/chemokine analysis.

Cytokine/chemokine profile analysis	Abbreviation	Size	Age (yrs)#	Gender M/F*	Dermatological description
Negative Control without lesion	CT L(−)	19	47	10/9	None
Negative Control with lesion	CT L(+)	25	41	14/11	Skin lesions
Total Negative control	CT	44	44	24/20
HTLV-1 carriers without lesion	HTLV-1+ L(−)	16	38	3/13	None
HTLV-1 carriers with lesion	HTLV-1+ L(+)	33	48	15/18	Skin lesions
Total HTLV-1+	HTLV-1+	49	43	18/31
Negative control with Autoimmune lesions	CT L(AI)	11	45	6/5	xerosis, acquired ichthyosis, psoriasis and pemphigus
HTLV-1 carriers with Autoimmune lesions	HTLV-1+ L(AI)	14	47	6/8
Negative control with Infectious lesions	CT L(INF)	14	37	8/6	dermatophytosis, candidiasis and Malassezia infections
HTLV-1 carriers with Infectious lesions	HTLV-1+ L(INF)	19	49	9/10

^#- Age average in years;

^*M/F – Male/Female ratio.